Roivant Sciences Ltd. (ROIV)
22.09
+0.75
(+3.51%)
USD |
NASDAQ |
Dec 12, 16:00
22.23
+0.14
(+0.63%)
After-Hours: 20:00
Roivant Sciences Shareholders Equity (Quarterly): 4.362B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 45.89B |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.90M |
| Autolus Therapeutics Plc | 265.45M |
| Tiziana Life Sciences Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.063B |
| Total Liabilities (Quarterly) | 257.14M |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 33.70 |
| Net Debt Paydown Yield | 0.54% |